About ENDRA Life Sciences
ENDRA Life Sciences (NASDAQ:NDRA) is a pioneering company focused on enhancing the capabilities of ultrasound technology to solve complex health problems. At its core, ENDRA aims to develop and commercialize Thermo Acoustic Enhanced UltraSound (TAEUS), a technology designed to provide clinicians with the ability to visualize tissue function and composition in ways previously possible only with CT or MRI, but at a fraction of the cost and with portability. This innovative approach opens new possibilities in diagnosing and monitoring diseases by making high-quality imaging more accessible and convenient. With projects spanning from early-stage clinical trials to partnerships aimed at integrating TAEUS into existing medical imaging workflows, ENDRA's objective is clear: to improve global health by making advanced imaging technology more affordable and widespread.
Snapshot
Operations
Products and/or services of ENDRA Life Sciences
- Development of TAEUS technology to assess non-alcoholic fatty liver disease (NAFLD) via ultrasound, providing a non-invasive, cost-effective diagnostic tool.
- Research into expanding TAEUS applications beyond NAFLD, targeting liver disease diagnostics and potentially other organ assessment.
- Partnerships with medical institutions and liver centers to conduct clinical studies, enhancing TAEUS validation and adoption.
- Collaboration with healthcare and technology companies to integrate TAEUS technology into existing ultrasound systems, broadening market reach.
- Efforts to secure regulatory approvals in key global markets, ensuring TAEUS meets international healthcare standards and requirements.
- Outreach and educational programs for healthcare professionals to increase awareness and understanding of TAEUS technology, supporting its clinical uptake.
ENDRA Life Sciences executive team
- Mr. Alexander Y. TokmanCEO & Chairman
- Mr. Richard JacrouxCFO & Secretary
- Dr. Jonathan Behr Ph.D.Co-Founder
- Mr. Scott SoberHead of Operations
- Mr. Ziad RouagHead of Regulatory & Clinical Affairs
- Mr. Idan SteinbergHead of Engineering